DePuy Synthes’ investment includes a 3D-printing Development and Launch Center and implementation of the Johnson & Johnson 3D Bioprinting Laboratory. Projects will focus on advancing materials in additive manufacturing, coatings and surface treatments.... Read more »
Additive manufacturing software company Betatype significantly increased the production of 3D-printed metal orthopaedic implants using its technology platform and Renishaw’s RenAM 500Q powder bed fusion printer.... Read more »
The company is a powder manufacturing subsidiary of GE Additive, located in Quebec, Canada.... Read more »
Rejoint's EBM additively-manufactured cobalt chrome YourKnee™ —which utilizes pre- and intra-op computer assisted technology, wearables, artificial intelligence and surgical simulation— achieved a first complete mechanical test. First surgery is slated for 1Q19 in Italy. Limited launch is... Read more »
PAPC can be used for 3D printing and molding of Class I and II devices for spine, trauma and arthroscopy/soft tissue applications.... Read more »
The company will initially offer a testing-grade version of the new material, followed by implant-grade in 1Q19.... Read more »
This acquisition expands Carpenter’s additive manufacturing capabilities.... Read more »
Evolve, a spinoff of Stratasys, aims to develop and commercialize a proprietary technology to compete with traditional manufacturing processes like injection molding. ... Read more »
An additive manufacturing expert from Osseus Fusion Systems shares how AM allows a small spine company to bring prototyping in-house for time and cost efficiencies while also maintaining surgeon engagement. ... Read more »
The collaboration will deliver a new concept in factory automation that will enable manufacturers to efficiently produce complex metal parts.... Read more »
The biomaterials compounding company manufactures Class I and II devices for spine, trauma and arthroscopy/soft tissue repair.... Read more »
An agency representative, and experts from ASTM, DePuy Synthes, and SME, talked additive regulatory issues at OMTEC 2018. Among the insight provided: "Have a good process flow map of all of the steps involved. People tend to focus on the printing portion, but there are a number of steps upstream and... Read more »
Gautam Gupta, Vice President of Business Development for the Healthcare division of 3D Systems, explains that "3D printing technology is at an inflection point and is well-positioned for adoption as a factory solution for large-scale production."... Read more »
The facility will initially focus on additive manufacturing technology development, with future investments slated for meltless titanium powder and other materials.... Read more »
The purchase of Nanosurfaces Industries is expected to boost Eurocoating’s additive capabilities.... Read more »
The company is producing spinal implants at this Netherlands facility.... Read more »
Siemens’ additive design and manufacturing software is being expanded to support HP’s new, full-color 3D printers.... Read more »
Smith will present mechanical test methods in AM as part of the event’s GE Additive Tech Center.... Read more »
AMUG is an organization that educates and advances the uses and applications of additive manufacturing technologies; the new board will be responsible for building and overseeing the group's 2019 conference.... Read more »
The company, specialists in additive manufacturing, is adding comprehensive machining and casting services.... Read more »
The company will add to its additive manufacturing capability with this strategic investment.... Read more »
The project involves additively manufactured zirconia-based ceramic orthopaedic implants.... Read more »
The company is adding a fifth 3D printer to its manufacturing facility.... Read more »
Joe Haniford and Mike Murtagh see roles change in a series of strategic moves.... Read more »
The $15 million center will employ up to 50 employees within the 29,000-square-foot facility.... Read more »
GE’s ownership stake in Arcam is now around 95%.... Read more »
The Härryda, Sweden space will open in 1Q19 ... Read more »
Oxford Performance Materials says that study results reveal superior antibacterial properties of PEKK structures compared to PEEK surfaces.... Read more »
FDA published its guidance on additive manufacturing technical considerations, outlining the Agency’s long-awaited position on use of the technology for medical devices.... Read more »
Arcam purchased DiSanto Technology in 2014 for US $15.8MM in cash and stock.... Read more »
The Lichtenfels, Germany facility will house around 500 employees and will open in early 2019.... Read more »
This global innovation hub will advance AM technical standards, related research and development, education, training and more.... Read more »
CarTech Puris 5+ exceeds the standard Ti 6Al-4V Grade 5 strength levels by nearly 18%.... Read more »
Companies announced numerous spine product regulatory decisions and market launches well in advance of the 2017 NASS Annual Meeting. We've recapped product updates as a guide for what you can see and hear about on the exhibit floor.... Read more »
The new manufacturing plant in Saint-Eustache will employe 106 staff by the end of 2017. ... Read more »
A new white paper produced by the Society of Manufacturing Engineers’ (SME) Medical Additive Manufacturing/3D Printing Workgroup offers an evidence-building framework that may be used to conduct studies and set guidelines.... Read more »
To allow GE Additive to meet the growing industry demand for additive components, they are seeking to identify companies to become certified additive production centers by the end of the year.... Read more »
MinebeaMitsumi acquired C&A Tool Engineering to expand its presence in medical, additive manufacturing, precision machining and ball bearings.... Read more »
Samuel’s purchase of Burloak Technologies allows Carpenter and Samuel to offer solutions from concept to delivery in additive manufacturing. ... Read more »
PTC's ThingWorx ® Platform is designed to help customers maximize productivity. ... Read more »
The launch unifies Arcam EBM, AP&C and DTI under GE Additive as one common brand structure. ... Read more »
Arcam's EBM operations will be led by General Manager, Karl Lindblom. ... Read more »
The $35MM purchase included manufacturing assets, patents and related IP. ... Read more »
As you consider your priorities for the AAOS Annual Meeting, keep in mind that the conference continues to attract exhibiting supplier and service providers. This list allows you to identify companies by their main capability.... Read more »
The Chinese government has prioritized medical device development, as well as local and international investments by domestic device companies. These initiatives, along with shifts in OEM to hospital distribution channels and newly-structured tiered healthcare, are expected to affect and shape the o... Read more »
The transaction provides immediate entry into the titanium powder market, much earlier than previously planned. ... Read more »
The initiative supports access to 3D printing technology for multiple industrial markets.... Read more »
The agreement allows for GE to take full ownership of Concept Laser over the next several years.... Read more »
Talk of the promise of additive manufacturing and 3D printing often centers on aspects of cost, speed, advanced designs, clinical outcomes. With any technology used in our highly-regulated, patient-facing industry, quality—of the process, of the machine, of the finished product, of the knowledge o... Read more »
GE will acquire a 75% stake in Concept Laser, manufacturer of additive manufacturing machines.... Read more »
The unknowns of additive manufacturing have held up some companies from fully committing to its adoption. But, this hasn’t stopped them from progressing and making significant investments. Here's some action from the last few months.... Read more »
AP&C plans to invest up to CAD 31MM in this facility, creating 106 new jobs within the next three years.... Read more »
GE plans to acquire Arcam and SLM Solutions, suppliers of additive manufacturing equipment, for US $1.4BB in cash.... Read more »
The orthopaedic industry has become more invested in additive manufacturing, as demonstrated by product launches, partnerships and FDA’s recent guidance document on the technology. But, what do surgeons think about it?... Read more »
Arcam, a supplier of Additive Manufacturing (AM) equipment, announced that its powder manufacturing subsidiary AP&C, in Montreal, Canada, has agreed with Investissement Québec (IQ) on a financing arrangement whereby IQ supports AP&C’s investment in a new powder plant with interest-free lo... Read more »
Evonik is investigating development of biodegradable high-strength composites. These materials could potentially replace metal in implants used for the internal fixation of fractured bones.
Today’s metallic devices typically remain in the body for the rest of the patient’s life or require a sec... Read more »
In order for additive manufacturing to move from tinkering technology to widely-used process, it’s imperative to prove its long-term benefits. In May, researchers, surgeons, device companies and additive manufacturing suppliers gathered to develop guidelines to build data and support reimbursement... Read more »
FDA published draft guidance on technical considerations for additive manufactured devices in response to the technology’s advancements and investments. Among the top concerns of FDA and industry are post-processing, cleaning and sterilizing devices.... Read more »
Arcam, supplier of Additive Manufacturing (AM) equipment, announced that its powder manufacturing subsidiary AP&C in Montreal, Canada, is building a new powder manufacturing plant.
The new facility will provide manufacturing redundancy, short term capacity increase and long term expansion capa... Read more »
Arcam, supplier of Additive Manufacturing technology, is expanding in Germany with a new sales operation led by Peter Jain, Managing Director of Arcam Cad to Metal GmbH, and based in Stuttgart.
With long term relationships with significant clients such as Fruth Innovation, Fraunhofer Institute and ... Read more »
Arcam launched Arcam Q10plus and Arcam Q20plus, a significantly enhanced generation of the Arcam Q-series EBM systems for Additive Manufacturing. With Qplus, Arcam introduces Arcam xQam™, an X-ray based function for high precision auto-calibration and improved beam control.
The Arcam Qplus-series... Read more »
FMI Instrumed, a contract manufacturer specializing in additive manufacturing, welding and high-precision machining, will commence production of serial orthopaedic titanium implants using a metal 3D printer. To obtain this capability, the company invested in a Concept Laser M2 Dual Laser metal print... Read more »
Industry trends such as bundled payments, additive manufacturing and robotics were hot topics at this year’s AAOS Annual Meeting.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Analysts have predicted that by 2018, 3D printing will result in a loss of $100 billion per year in IP globally. Here is a look at why enforcing one’s IP against 3D printer infringers will be challenging.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
